Regulations.gov document
Guidance for Industry; Residual Drug in Transdermal and Related Drug Delivery Systems
Notice · FDA-2010-D-0246 · posted Aug 17, 2011
Key facts
| Document ID | FDA-2010-D-0246-0013 |
|---|---|
| Title | Guidance for Industry; Residual Drug in Transdermal and Related Drug Delivery Systems |
| Document type | Notice |
| Subtype | Notice of Availability |
| Agency | FDA |
| Docket | FDA-2010-D-0246 |
| Posted | Aug 17, 2011 |
| Federal Register citation | 76FR51038 |
| FR document number | 2011-20852 |
| Comment period opens | Aug 17, 2011 |
At a glance
- 1–9 Pages
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: